Atopic dermatitis, a chronic inflammatory skin condition, affects millions worldwide. We delve deep into the intricacies of this condition, exploring its causes, symptoms, and the impact it has on daily life. Our research aims to demystify atopic dermatitis, paving the way for more effective treatments and improved quality of life.
You have the power to make a difference! Participate in our clinical trials and contribute to the advancement of atopic dermatitis research. Your involvement not only aids in the development of new therapies but also brings us one step closer to a world where individuals with atopic dermatitis can live without the burden of constant itching and discomfort
Our trial is designed to:
​
-
Access to innovative treatments: By participating in our clinical trial, you will have the opportunity to receive cutting-edge treatments that could potentially improve your Atopic Dermatitis symptoms and overall quality of life.
​
-
Expert medical care: The D&H National Research Centers team of healthcare professionals and researchers will closely monitor your progress throughout the trial, ensuring that you receive the highest standard of care and support.
​
-
Contribution to medical research: By participating in our clinical trial, you will be contributing to the advancement of medical science and helping to improve the lives of future Atopic Dermatitis patients.
​
-
Compensation: As a token of appreciation for your participation, you may be eligible for compensation for your time and travel expenses up $1000.
D&H National Research Centers is currently conducting a study on Atopic Dermatitis. As a prominent leader in clinical research in Florida, we are committed to advancing medical knowledge and patient care.
Inclusion Criteria:
If you want to participate in this study, you must meet the following criteria:
​
-
Male or female subjects aged from 12 to 54 years old (both inclusive).
-
History of Atopic Dermatitis over the previous 12 months.
-
Have a history of inadequate response to treatment with topical medications; or
determination that topical treatments are otherwise medically inadvisable.
Exclusion Criteria:
You are not eligible for participation in this study if:
-
History of human immunodeficiency virus (HIV) infection or positive HIV serology, Hepatitis B or C at screening.
-
Have known liver cirrhosis and/or chronic hepatitis of any etiology.
History of malignancy, including mycosis fungoides or cutaneous T-cell lymphoma,
within 5 years before the screening. -
Are diagnosed with active endoparasitic infections or at high risk of these infections.
​
D&H National Research Centers is a leading medical trial center located in Florida.
​
If you are interested in joining our Atopic Dermatitis medical trial or have questions about the study, please don't hesitate to reach out to us. We are here to provide you with all the information and support you need, please fill out the form or contact us by phone: (786) 375-6210